FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

M Pouteau

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Sarah Maylin; Michèle Martinot-Peignoux; Marie-Pierre Ripault; Rami Moucari; Ana Carolina Cardoso; Nathalie Boyer; Nathalie Giuily; Corinne Castelnau; M Pouteau; Tarik Asselah; Marie-Hélène Nicolas-Chanoine; Patrick Marcellin
Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody.
Michelle Martinot-Peignoux; Sarah Maylin; Rami Moucari; Marie-Pierre Ripault; Nathalie Boyer; Ana-Carolina Cardoso; Nathalie Giuily; Corinne Castelnau; M Pouteau; Christiane Stern; Anne Aupérin; Pierre Bedossa; Tarik Asselah; Patrick Marcellin
Virological response at 4 weeks to predict outcome of hepatitis C treatment with pegylated interferon and ribavirin.
Michèle Martinot-Peignoux; Nathalie Boyer; M Pouteau; Corinne Castelnau; Nathalie Giuily; V Duchatelle; A Aupérin; Claude Degott; Jean-Pierre Benhamou; S Erlinger; Patrick Marcellin
Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of M Pouteau (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Sarah Maylin; Michèle Martinot-Peignoux; Marie-Pierre Ripault; Rami Moucari; Ana Carolina Cardoso; Nathalie Boyer; Nathalie Giuily; Corinne Castelnau; M Pouteau; Tarik Asselah; Marie-Hélène Nicolas-Chanoine; Patrick Marcellin
Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody.
Liver international : official journal of the International Association for the Study of the Liver 2009;29(4):511-7.
2009: Michelle Martinot-Peignoux; Sarah Maylin; Rami Moucari; Marie-Pierre Ripault; Nathalie Boyer; Ana-Carolina Cardoso; Nathalie Giuily; Corinne Castelnau; M Pouteau; Christiane Stern; Anne Aupérin; Pierre Bedossa; Tarik Asselah; Patrick Marcellin
Virological response at 4 weeks to predict outcome of hepatitis C treatment with pegylated interferon and ribavirin.
Antiviral therapy 2009;14(4):501-11.
1998: Michèle Martinot-Peignoux; Nathalie Boyer; M Pouteau; Corinne Castelnau; Nathalie Giuily; V Duchatelle; A Aupérin; Claude Degott; Jean-Pierre Benhamou; S Erlinger; Patrick Marcellin
Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.
Journal of hepatology 1998;29(2):214-23.
1998: V Duchatelle; Patrick Marcellin; E Giostra; L Bregeaud; M Pouteau; Nathalie Boyer; A Auperin; S Guerret; S Erlinger; D Henin; Claude Degott
Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: quantitative assessment by a morphometric method.
Journal of hepatology 1998;29(1):20-8.
1998: W C Chow; Nathalie Boyer; M Pouteau; Corinne Castelnau; Michèle Martinot-Peignoux; V Martins-Amado; Françoise Degos; C Maghinici; M Sinegre; Jean-Pierre Benhamou; Claude Degott; S Erlinger; Patrick Marcellin
Re-treatment with interferon alfa of patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 1998;27(4):1144-8.
1997: Patrick Marcellin; Nathalie Boyer; A Gervais; Michèle Martinot; M Pouteau; Corinne Castelnau; A Kilani; J Areias; A Auperin; Jean-Pierre Benhamou; Claude Degott; S Erlinger
Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
Annals of internal medicine 1997;127(10):875-81.
1997: Michèle Martinot; Patrick Marcellin; Nathalie Boyer; Jill Detmer; M Pouteau; Corinne Castelnau; Claude Degott; A Aupérin; M Collins; Janice A Kolberg; J Wilber; Jean-Pierre Benhamou; S Erlinger
Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C.
Annals of internal medicine 1997;126(11):874-81.
1995: Patrick Marcellin; M Pouteau; Michèle Martinot; Nathalie Boyer; Corinne Castelnau; Jean-Pierre Benhamou; S Erlinger
[Factors of response to treatment with interferon-alpha in patients with chronic hepatitis C. Therapeutic perspectives].
Gastroentérologie clinique et biologique 1995;19(12):991-1000.
1995: Michèle Martinot-Peignoux; Patrick Marcellin; M Pouteau; Corinne Castelnau; Nathalie Boyer; M Poliquin; Claude Degott; I Descombes; V Le Breton; V Milotova
Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.
Hepatology (Baltimore, Md.) 1995;22(4 Pt 1):1050-6.
1995: Patrick Marcellin; M Pouteau; Michèle Martinot-Peignoux; Françoise Degos; V Duchatelle; Nathalie Boyer; C Lemonnier; Claude Degott; S Erlinger; Jean-Pierre Benhamou
Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C.
Gastroenterology 1995;109(1):156-65.
1995: Patrick Marcellin; M Pouteau; Jean-Pierre Benhamou
Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction.
Journal of hepatology 1995;22(3):364-9.
1995: Patrick Marcellin; M Pouteau; M A Loriot; Nathalie Boyer; Françoise Degos; P Calès; L Bettan; Y Bacq; H Coppére; jean didier grange
Adenine arabinoside 5'-monophosphate in patients with chronic hepatitis B: comparison of the efficacy in patients with high and low viral replication.
Gut 1995;36(3):422-6.
1994: Nicole Colas-Linhart; B Bok; Patrick Marcellin; M Pouteau; Jean-Pierre Benhamou
Anti-thyroid autoantibodies and hepatitis C virus.
Hepatology (Baltimore, Md.) 1994;20(6):1649-50.
1994: Patrick Marcellin; Nathalie Boyer; M Pouteau; Jean-Pierre Benhamou; S Erlinger
Retreatment with interferon-alpha of chronic hepatitis C virus infection.
Lancet 1994;344(8923):690-1.
1993: E Baudin; Patrick Marcellin; M Pouteau; Nicole Colas-Linhart; J P Le Floch; C Lemmonier; Jean-Pierre Benhamou; Bernard Bok
Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C.
Clinical endocrinology 1993;39(6):657-61.
1993: Patrick Marcellin; M Pouteau; Nathalie Boyer; Corinne Castelnau; S Erlinger; Jean-Pierre Benhamou
Retreatment with recombinant interferon-alpha in patients with chronic hepatitis C.
The Journal of infectious diseases 1993;167(3):780-1.
1993: Patrick Marcellin; M Pouteau; O Messian; Bernard Bok; S Erlinger; Jean-Pierre Benhamou
[Hepatitis C virus, interferon alpha, and dysthyroidism].
Gastroentérologie clinique et biologique 1993;17(12):887-91.
1992: Patrick Marcellin; M Pouteau; P Renard; J M Grynblat; Nicole Colas-Linhart; P Bardet; Bernard Bok; Jean-Pierre Benhamou
Sustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis C.
Gut 1992;33(6):855-6.
1991: Patrick Marcellin; Michèle Martinot-Peignoux; Nathalie Boyer; M Pouteau; P Aumont; S Erlinger; Jean-Pierre Benhamou
Second generation (RIBA) test in diagnosis of chronic hepatitis C.
Lancet 1991;337(8740):551-2.